Results 71 to 80 of about 14,826 (163)

Multiply doses of FDC of rosuvastatin and ezetimibe versus rosuvastatin monotherapy in Chinese patients with hypercholesterolemia (ROSE-CH): multicenter, randomized-controlled trial

Lipids in Health and Disease
Objective Rosuvastatin plus ezetimibe improves the lipid-lowering effect through different mechanisms of action. This study intended to compare the efficacy and safety of the fixed-dose combination (FDC) of rosuvastatin/ezetimibe vs.
Xianyou Ji, Jinlan Xia, Hong Zhang, Changjie Ren, Guang Ma, Shenwen Fu, Jun Zhang, Ying Chen, Xuebin Han, Jianming Zhang, Zhengxu Fang, Bo Yang, Baisong Yang, Wenjun Huang, Gang Yin, Hong Qi, Hao Gong, Dongfang Wang, Liuyi Hao, Xiufeng Zhao, Zhaohui Pei, Peijian Wang, Xiaodong Li, Ling Lin, De Li, Zhi Li, Lin Zhang, Bo Yin, Ying Cheng, Zhiqing You, Jianlong Sheng, Jie Wu, Ling Chen, Zhongcai Fan, Wang Zhao, Shuiping Zhao   +35 more
doaj   +1 more source

ZETIA (ezetimibe) [PDF]

Congestive Heart Failure, 2003
openaire   +2 more sources

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia

Vascular Health and Risk Management, 2010
Ian Hamilton-Craig1, Karam Kostner2, David Colquhoun2, Stan Woodhouse21Griffith University School of Medicine, Southport, Queensland, Australia; 2University of Queensland, Brisbane, Queensland, AustraliaAbstract: High-dose potent statin therapy in ...
Ian Hamilton-Craig, Karam Kostner, David Colquhoun, et al   +3 more
doaj  

A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease. [PDF]

Am J Cardiovasc Drugs
Liu HH, Liu ZH, Chen SS, Zhu CG, Li JJ.
europepmc   +1 more source

Pilot study of the use of ezetimibe in dogs with hyperlipidemia. [PDF]

Vet Res Commun
de Lima Wachholz P, Bierhals ES, de Lima CM, Grala CX, de Freitas VR, Jorge S, Bruhn FRP, de Oliveira Nobre M, Rondelli MCH.   +8 more
europepmc   +1 more source

Cost-utility analysis of add-on ezetimibe to moderate-intensity statin versus moderate-intensity statin alone for secondary prevention in patients with acute coronary syndrome intolerant to high-intensity statin therapy in Thailand. [PDF]

Front Pharmacol
Promchit N, Chinwong S, Permsuwan U.
europepmc   +1 more source

Early escalation of oral lipid-lowering therapy to achieve LDL-cholesterol targets in patients after myocardial infarction: study protocol for the prospective, open-label HAnnover ChOlesterol Lowering in Acute Coronary Syndrome trial. [PDF]

Front Cardiovasc Med
Schäfer A, Großhennig A, Theis L, Schindler C, Grahl E, Stichtenoth DO, König T, Geller WA, Schmidt HHJG, Bavendiek U, Bauersachs J.   +10 more
europepmc   +1 more source

Real-World Safety and Efficacy of a Pitavastatin-Ezetimibe Combination Therapy in Taiwanese Patients after PCI. [PDF]

Acta Cardiol Sin
Lu YW, Fang CC, Cheng YT.
europepmc   +1 more source

Ezetimibe Normalizes Dietary Cholesterol-Induced Exacerbation of Liver Injury in Alcohol-Fed Mice. [PDF]

Biomolecules
Xu Y, Zhang N, Wickramasinghe PB, Veera K, Parupalli P, Dao A, Liu J, Anand R, Langley LE, Eadha S, Iqbal H, Liu C, Bian F, Jia L.   +13 more
europepmc   +1 more source

Combination therapy with moderate-intensity statins and ezetimibe and risk of incident PCI/CABG in atherosclerotic cardiovascular disease: a propensity-matched cohort study. [PDF]

Lancet Reg Health West Pac
He H, Tang J, Yan VKC, Blais JE, Wong CK, Tam MTK, Yiu HHE, Tse HF, Chan EWY.   +8 more
europepmc   +1 more source